<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02112370</url>
  </required_header>
  <id_info>
    <org_study_id>B-1403/242-006</org_study_id>
    <nct_id>NCT02112370</nct_id>
  </id_info>
  <brief_title>Efficacy of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy</brief_title>
  <acronym>REBT</acronym>
  <official_title>Phase 3 Study of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the pain relief and the hemodynamic stability of ropivacaine with epinephrine in
      BABA endoscopic and robotic thyroidectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diluted ropivacaine with epinephrine is injected into the subcutaneous space to relieve pain
      and reduce bleeding during procedures. The synergistic effect of ropivacaine with epinephrine
      can contribute to patients' welfare, such as relieving pain and structuring the hemodynamic
      stability.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>NRS Pain Scores for the First 12 Hours</measure>
    <time_frame>Postoperative 12 hours</time_frame>
    <description>The numerical rating scale is utilized to assess the postoperative pain change for the first 12 hours according to location.
Range: 0(minimal pain, better outcome) ~ 10(maximum pain, worse outcome)
Unlike the general NRS pain score as reported in the &quot;post-operative 48 hour&quot; result which deals with post-operative discomfort in general, this outcome measures the pain score of the specific location in which flap dissection had taken place.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximum of Measured Systolic Blood Pressures</measure>
    <time_frame>participants were followed for the duration of the operation, an average of approximately 2.5 hours</time_frame>
    <description>The maximal systolic blood pressure is monitored during surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum of Measured Diastolic Blood Pressures</measure>
    <time_frame>participants were followed for the duration of the operation, an average of approximately 2.5 hours</time_frame>
    <description>The maximal diastolic blood pressure is monitored during surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum of Measured Heart Rates</measure>
    <time_frame>participants were followed for the duration of the operation, an average of approximately 2.5 hours</time_frame>
    <description>The maximal heart rate is monitored during surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Loss Amount</measure>
    <time_frame>participants were followed for the duration of the operation, an average of approximately 2.5 hours</time_frame>
    <description>The blood loss amount is estimated at the end of surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operation Time</measure>
    <time_frame>participants were followed for the duration of the operation, an average of approximately 2.5 hours</time_frame>
    <description>The amount of time taken from start to the end of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NRS Change</measure>
    <time_frame>0, 1, 2, 4, 6, 9, 12, 24, and 48 hours post operation</time_frame>
    <description>Change in NRS score a with time The numerical rating scale is utilized to assess the postoperative pain change for the first 12 hours according to location.
Range: 0(minimal pain, better outcome) ~ 10(maximum pain, worse outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Killer Dose</measure>
    <time_frame>0, 1, 2, 4, 6, 9, 12, 24, and 48 hours post operation</time_frame>
    <description>Change in pain killer usage with time</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">148</enrollment>
  <condition>Thyroid Neoplasm</condition>
  <condition>Goiter</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine with epinephrine injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine with epinephrine injection</intervention_name>
    <description>1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection for the experiment group.</description>
    <arm_group_label>Ropivacaine with epinephrine injection</arm_group_label>
    <other_name>Hanlim ropiva injection 7.5 mg/mL (20cc)</other_name>
    <other_name>Insurance code: A37804211</other_name>
    <other_name>Jeil epinephrine injection 1 mg/mL (1cc)</other_name>
    <other_name>Insurance code: A04900341</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>100cc normal saline is injected into the subcutaneous layer for the initial flap dissection for the placebo group.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>CJ 0.9% Normal Saline injection 100cc</other_name>
    <other_name>Insurance code: A11601752</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of thyroid neoplasm or benign goiter

          -  Scheduled for BABA endoscopic or robotic thyroidectomy

        Exclusion Criteria:

          -  Completion thyroidectomy

          -  Modified radical neck dissection

          -  Allergy history

          -  Stroke history

          -  Uncontrolled hypertension

          -  Uncontrolled diabetes

          -  Coagulopathy

          -  Severe cardiovascular disease

          -  Severe pulmonary disease

          -  Chronic kidney disease

          -  Pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyu Eun Lee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <link>
    <url>http://www.frca.co.uk/article.aspx?articleid=100816</url>
    <description>Pharmacology of regional anaesthesia</description>
  </link>
  <reference>
    <citation>Hristovska AM, Kristensen BB, Rasmussen MA, Rasmussen YH, Elving LB, Nielsen CV, Kehlet H. Effect of systematic local infiltration analgesia on postoperative pain in vaginal hysterectomy: a randomized, placebo-controlled trial. Acta Obstet Gynecol Scand. 2014 Mar;93(3):233-8. doi: 10.1111/aogs.12319.</citation>
    <PMID>24576202</PMID>
  </reference>
  <reference>
    <citation>Miratashi SA, Behdad S, Ayatollahi V, Ahmadi A. Hemodynamic effects of intraocular epinephrine during cataract surgery: a double blinded placebo controlled randomized clinical trial. Nepal J Ophthalmol. 2012 Jul-Dec;4(2):288-94. doi: http://dx.doi.org/10.3126/nepjoph.v4i2.6546.</citation>
    <PMID>22864036</PMID>
  </reference>
  <reference>
    <citation>Kim SJ, Lee KE, Myong JP, Koo do H, Lee J, Youn YK. Prospective study of sensation in anterior chest areas before and after a bilateral axillo-breast approach for endoscopic/robotic thyroid surgery. World J Surg. 2013 May;37(5):1147-53. doi: 10.1007/s00268-013-1934-8.</citation>
    <PMID>23397168</PMID>
  </reference>
  <reference>
    <citation>Lee KE, Choi JY, Youn YK. Bilateral axillo-breast approach robotic thyroidectomy. Surg Laparosc Endosc Percutan Tech. 2011 Aug;21(4):230-6. doi: 10.1097/SLE.0b013e31822d0455.</citation>
    <PMID>21857470</PMID>
  </reference>
  <reference>
    <citation>Choe JH, Kim SW, Chung KW, Park KS, Han W, Noh DY, Oh SK, Youn YK. Endoscopic thyroidectomy using a new bilateral axillo-breast approach. World J Surg. 2007 Mar;31(3):601-6.</citation>
    <PMID>17308853</PMID>
  </reference>
  <reference>
    <citation>Choi JY, Lee KE, Chung KW, Kim SW, Choe JH, Koo do H, Kim SJ, Lee J, Chung YS, Oh SK, Youn YK. Endoscopic thyroidectomy via bilateral axillo-breast approach (BABA): review of 512 cases in a single institute. Surg Endosc. 2012 Apr;26(4):948-55. doi: 10.1007/s00464-011-1973-x. Epub 2011 Nov 4.</citation>
    <PMID>22052422</PMID>
  </reference>
  <reference>
    <citation>Kwon H, Koo do H, Choi JY, Kim E, Lee KE, Youn YK. Bilateral axillo-breast approach robotic thyroidectomy for Graves' disease: an initial experience in a single institute. World J Surg. 2013 Jul;37(7):1576-81. doi: 10.1007/s00268-013-2027-4.</citation>
    <PMID>23558759</PMID>
  </reference>
  <reference>
    <citation>Lee KE, Kim E, Koo do H, Choi JY, Kim KH, Youn YK. Robotic thyroidectomy by bilateral axillo-breast approach: review of 1,026 cases and surgical completeness. Surg Endosc. 2013 Aug;27(8):2955-62. doi: 10.1007/s00464-013-2863-1. Epub 2013 Feb 23.</citation>
    <PMID>23436099</PMID>
  </reference>
  <reference>
    <citation>Lee KE, Koo do H, Im HJ, Park SK, Choi JY, Paeng JC, Chung JK, Oh SK, Youn YK. Surgical completeness of bilateral axillo-breast approach robotic thyroidectomy: comparison with conventional open thyroidectomy after propensity score matching. Surgery. 2011 Dec;150(6):1266-74. doi: 10.1016/j.surg.2011.09.015.</citation>
    <PMID>22136850</PMID>
  </reference>
  <reference>
    <citation>Lee KE, Rao J, Youn YK. Endoscopic thyroidectomy with the da Vinci robot system using the bilateral axillary breast approach (BABA) technique: our initial experience. Surg Laparosc Endosc Percutan Tech. 2009 Jun;19(3):e71-5. doi: 10.1097/SLE.0b013e3181a4ccae.</citation>
    <PMID>19542833</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2014</study_first_submitted>
  <study_first_submitted_qc>April 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2014</study_first_posted>
  <results_first_submitted>June 7, 2016</results_first_submitted>
  <results_first_submitted_qc>April 25, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">August 4, 2017</results_first_posted>
  <last_update_submitted>April 25, 2017</last_update_submitted>
  <last_update_submitted_qc>April 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Kyu Eun Lee</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Ropivacaine</keyword>
  <keyword>Epinephrine</keyword>
  <keyword>Endoscopy</keyword>
  <keyword>Robotics</keyword>
  <keyword>Thyroidectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Normal Saline Injection</title>
          <description>100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.
Placebo: 100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.</description>
        </group>
        <group group_id="P2">
          <title>Ropivacaine With Epinephrine Injection</title>
          <description>1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.
Ropivacaine with epinephrine injection: 1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="74"/>
                <participants group_id="P2" count="74"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="74"/>
                <participants group_id="P2" count="74"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All patients referred for BABA robotic or endoscopic thyroidectomy at Seoul National University Bundang Hospital</population>
      <group_list>
        <group group_id="B1">
          <title>Normal Saline Injection</title>
          <description>100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.
Placebo: 100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.</description>
        </group>
        <group group_id="B2">
          <title>Ropivacaine With Epinephrine Injection</title>
          <description>1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.
Ropivacaine with epinephrine injection: 1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="74"/>
            <count group_id="B2" value="74"/>
            <count group_id="B3" value="148"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.0" spread="9.3"/>
                    <measurement group_id="B2" value="35.5" spread="8.8"/>
                    <measurement group_id="B3" value="36.1" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="66"/>
                    <measurement group_id="B3" value="135"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Preoperative thyroid function test (T3, ng/dL)</title>
          <units>ng/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="121.8" spread="15.0"/>
                    <measurement group_id="B2" value="123.3" spread="25.1"/>
                    <measurement group_id="B3" value="122.5" spread="20.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Preoperative thyroid function test (free T4, ng/dL)</title>
          <units>ng/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.2" spread="0.3"/>
                    <measurement group_id="B2" value="1.2" spread="0.4"/>
                    <measurement group_id="B3" value="1.2" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Preoperative thyroid function test (TSH, uIU/mL)</title>
          <units>uIU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.8" spread="1.0"/>
                    <measurement group_id="B2" value="2.2" spread="1.7"/>
                    <measurement group_id="B3" value="2.0" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Method of operation (robotic/endoscopic)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Robotic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Endoscopic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Extent of operation (Right/Left/Total)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Right</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>NRS Pain Scores for the First 12 Hours</title>
        <description>The numerical rating scale is utilized to assess the postoperative pain change for the first 12 hours according to location.
Range: 0(minimal pain, better outcome) ~ 10(maximum pain, worse outcome)
Unlike the general NRS pain score as reported in the &quot;post-operative 48 hour&quot; result which deals with post-operative discomfort in general, this outcome measures the pain score of the specific location in which flap dissection had taken place.</description>
        <time_frame>Postoperative 12 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Injection</title>
            <description>100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.
Placebo: 100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine With Epinephrine Injection</title>
            <description>1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.
Ropivacaine with epinephrine injection: 1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>NRS Pain Scores for the First 12 Hours</title>
          <description>The numerical rating scale is utilized to assess the postoperative pain change for the first 12 hours according to location.
Range: 0(minimal pain, better outcome) ~ 10(maximum pain, worse outcome)
Unlike the general NRS pain score as reported in the &quot;post-operative 48 hour&quot; result which deals with post-operative discomfort in general, this outcome measures the pain score of the specific location in which flap dissection had taken place.</description>
          <units>points</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Swallowing difficulty</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.93" spread="1.79"/>
                    <measurement group_id="O2" value="4.12" spread="1.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anterior neck pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.50" spread="2.10"/>
                    <measurement group_id="O2" value="3.69" spread="1.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right chest pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.99" spread="2.27"/>
                    <measurement group_id="O2" value="3.16" spread="1.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left chest pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.74" spread="1.94"/>
                    <measurement group_id="O2" value="4.51" spread="2.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Back pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.65" spread="1.50"/>
                    <measurement group_id="O2" value="0.28" spread="1.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Posterior neck pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.47" spread="2.07"/>
                    <measurement group_id="O2" value="1.65" spread="2.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Swallowing difficulty</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.008</p_value>
            <p_value_desc>threshold p value for significance &lt; 0.05</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Anterior neck pain</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.016</p_value>
            <p_value_desc>threshold p value for significance &lt; 0.05</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Right chest pain</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.019</p_value>
            <p_value_desc>threshold p value for significance &lt; 0.05</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Left chest pain</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.035</p_value>
            <p_value_desc>threshold p value for significance &lt; 0.05</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Back pain</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.089</p_value>
            <p_value_desc>threshold p value for significance &lt; 0.05</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Posterior neck pain</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.634</p_value>
            <p_value_desc>threshold p value for significance &lt; 0.05</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximum of Measured Systolic Blood Pressures</title>
        <description>The maximal systolic blood pressure is monitored during surgery.</description>
        <time_frame>participants were followed for the duration of the operation, an average of approximately 2.5 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Injection</title>
            <description>100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.
Placebo: 100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine With Epinephrine Injection</title>
            <description>1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.
Ropivacaine with epinephrine injection: 1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>Maximum of Measured Systolic Blood Pressures</title>
          <description>The maximal systolic blood pressure is monitored during surgery.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="142" spread="16.5"/>
                    <measurement group_id="O2" value="145" spread="18.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximum of Measured Diastolic Blood Pressures</title>
        <description>The maximal diastolic blood pressure is monitored during surgery.</description>
        <time_frame>participants were followed for the duration of the operation, an average of approximately 2.5 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Injection</title>
            <description>100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.
Placebo: 100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine With Epinephrine Injection</title>
            <description>1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.
Ropivacaine with epinephrine injection: 1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>Maximum of Measured Diastolic Blood Pressures</title>
          <description>The maximal diastolic blood pressure is monitored during surgery.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91" spread="14.9"/>
                    <measurement group_id="O2" value="86" spread="19.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximum of Measured Heart Rates</title>
        <description>The maximal heart rate is monitored during surgery.</description>
        <time_frame>participants were followed for the duration of the operation, an average of approximately 2.5 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Injection</title>
            <description>100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.
Placebo: 100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine With Epinephrine Injection</title>
            <description>1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.
Ropivacaine with epinephrine injection: 1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>Maximum of Measured Heart Rates</title>
          <description>The maximal heart rate is monitored during surgery.</description>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" spread="16.1"/>
                    <measurement group_id="O2" value="99" spread="13.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Loss Amount</title>
        <description>The blood loss amount is estimated at the end of surgery.</description>
        <time_frame>participants were followed for the duration of the operation, an average of approximately 2.5 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Injection</title>
            <description>100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.
Placebo: 100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine With Epinephrine Injection</title>
            <description>1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.
Ropivacaine with epinephrine injection: 1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Loss Amount</title>
          <description>The blood loss amount is estimated at the end of surgery.</description>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" spread="58.2"/>
                    <measurement group_id="O2" value="18" spread="40.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Operation Time</title>
        <description>The amount of time taken from start to the end of surgery</description>
        <time_frame>participants were followed for the duration of the operation, an average of approximately 2.5 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Injection</title>
            <description>100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.
Placebo: 100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine With Epinephrine Injection</title>
            <description>1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.
Ropivacaine with epinephrine injection: 1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>Operation Time</title>
          <description>The amount of time taken from start to the end of surgery</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="163.6" spread="54.1"/>
                    <measurement group_id="O2" value="155.3" spread="46.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>NRS Change</title>
        <description>Change in NRS score a with time The numerical rating scale is utilized to assess the postoperative pain change for the first 12 hours according to location.
Range: 0(minimal pain, better outcome) ~ 10(maximum pain, worse outcome)</description>
        <time_frame>0, 1, 2, 4, 6, 9, 12, 24, and 48 hours post operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Injection</title>
            <description>100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.
Placebo: 100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine With Epinephrine Injection</title>
            <description>1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.
Ropivacaine with epinephrine injection: 1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>NRS Change</title>
          <description>Change in NRS score a with time The numerical rating scale is utilized to assess the postoperative pain change for the first 12 hours according to location.
Range: 0(minimal pain, better outcome) ~ 10(maximum pain, worse outcome)</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.73" spread="2.02"/>
                    <measurement group_id="O2" value="5.68" spread="2.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.05" spread="1.95"/>
                    <measurement group_id="O2" value="4.7" spread="1.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.55" spread="1.80"/>
                    <measurement group_id="O2" value="4.11" spread="1.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.55" spread="1.27"/>
                    <measurement group_id="O2" value="3.34" spread="1.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.39" spread="1.29"/>
                    <measurement group_id="O2" value="3.28" spread="1.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.28" spread="1.34"/>
                    <measurement group_id="O2" value="3.14" spread="1.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.19" spread="1.37"/>
                    <measurement group_id="O2" value="3.18" spread="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.93" spread="1.09"/>
                    <measurement group_id="O2" value="2.95" spread="1.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.27" spread="0.94"/>
                    <measurement group_id="O2" value="2.08" spread="0.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Killer Dose</title>
        <description>Change in pain killer usage with time</description>
        <time_frame>0, 1, 2, 4, 6, 9, 12, 24, and 48 hours post operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Injection</title>
            <description>100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.
Placebo: 100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine With Epinephrine Injection</title>
            <description>1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.
Ropivacaine with epinephrine injection: 1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Killer Dose</title>
          <description>Change in pain killer usage with time</description>
          <units>vials (15mg ketorolac per vial)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" spread="0.72"/>
                    <measurement group_id="O2" value="0.84" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.35" spread="0.51"/>
                    <measurement group_id="O2" value="0.31" spread="0.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="0.49"/>
                    <measurement group_id="O2" value="0.26" spread="0.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.25"/>
                    <measurement group_id="O2" value="0.11" spread="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.18" spread="0.38"/>
                    <measurement group_id="O2" value="0.15" spread="0.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.34"/>
                    <measurement group_id="O2" value="0.12" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.18" spread="0.42"/>
                    <measurement group_id="O2" value="0.19" spread="0.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.20" spread="0.44"/>
                    <measurement group_id="O2" value="0.16" spread="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.11"/>
                    <measurement group_id="O2" value="0.07" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Normal Saline Injection</title>
          <description>100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.
Placebo: 100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.</description>
        </group>
        <group group_id="E2">
          <title>Ropivacaine With Epinephrine Injection</title>
          <description>1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.
Ropivacaine with epinephrine injection: 1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="74"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="74"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Single-institution study
We did not directly examine the vasoconstrictive properties of epinephrine in helping reduce bleeding.
Issue regarding importance of statistical vs. clinical significance of the pain score remains to be addressed</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Kyu Eun Lee</name_or_title>
      <organization>Seoul National University Hospital Department of Surgery</organization>
      <phone>+82)-2-2072-2817</phone>
      <email>kyueunlee@snu.ac.kr</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

